Analystreport

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com